Microbot Medical’s robotic surgical system meets all objectives in study

Microbot Medical announced the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, monitoring, and reporting, using a porcine model. The study was conducted by three interventional radiologists that utilized Microbot’s Liberty Endovascular Robotic Surgical System to perform a total of 96 robotic navigations. Target vessels with surrounding tissue were examined and evaluated microscopically after they were subjected to procedures using a range of commercially available intravascular catheterization devices controlled and manipulated via the Liberty Endovascular Robotic Surgical System. The company expects to submit an IDE application to the FDA soon and commence a pivotal human clinical trial.